Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04476589 · ClinicalTrials.gov registry record
Prognostication of Recovery in Early Disorders of Consciousness After COVID-19
A clinical trial of Covid19 and Coma, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 12
- Enrollment target
- 1
- Study location
NCT04476589 is a study of Covid19 and Coma that has completed, run by Massachusetts General Hospital. The registered enrollment target is 12 participants, below the 2,702-participant average among 94 other Covid19 trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04476589, a study of Covid19 and Coma, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this research proposal is to use multimodal metrics (e.g., clinical data and advanced neuroimaging) in the early (i.e., acute hospitalization) phase of recovery from COVID-19-related disorders of consciousness to predict outcome at 3, 6, and 12 months post-hospitalization. We aim to construct an algorithm that synthesizes the results of these metrics to help predict recovery.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Functional MRI
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2020-07-01 |
| Est. Completion | 2022-04-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04476589
The ClinicalTrials.gov registry entry for NCT04476589 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,702-participant average among 94 other Covid19 trials with a reported enrollment target (100% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Covid19 appearing as the primary indexed condition, and to 1 intervention - of which Functional MRI is the first listed.
NCT04476589 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04476589 about?
NCT04476589 is a clinical study titled "Prognostication of Recovery in Early Disorders of Consciousness After COVID-19". The primary aim of this research proposal is to use multimodal metrics (e.g., clinical data and advanced neuroimaging) in the early (i.e., acute hospitalization) phase of recovery from COVID-19-related disorders of consciousness to predict outcome at 3, 6, and 12 months post-hospitalization. We aim ...
What is the current status of trial NCT04476589?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2020-07-01. Estimated completion is 2022-04-07.
What conditions does trial NCT04476589 study?
This clinical trial studies the following conditions: Covid19, Coma, Consciousness Disorder.
What interventions are being tested in trial NCT04476589?
The interventions under investigation include: Functional MRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04476589?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04476589 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Covid19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Immune Activation in COVID-19
RECRUITING · Phase 2
-
Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
RECRUITING · Phase 2
-
COVID-19 Vaccines International Pregnancy Exposure Registry
RECRUITING
-
COVID-19 Survivorship Registry
RECRUITING
-
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
RECRUITING · Phase 3
-
Conversations You Want About Corona Virus Disease (COVID-19)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.